ArticlebioRxiv : the preprint server for biology2026
EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming.
Avery R Childress et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.